Need advice on disclosing an invention?
Learn more »
Interested in our spin-out activity?
Learn more »
Read our 2011 Annual Review
Download the pdf »
Latest licencing opportunities
-
Stable human cell line for ubiquitin research
A stable human cell line expressing multiple copies of biotinylated ubiquitin under ...
-
Viral CD30 for treating inflammatory disease
A viral CD30 polypeptide that may be used to treat inflammatory diseases ...
Latest reagents
-
Recombinant Human RAD51 protein
<p>Recombinant full length human RAD51 protein purified from bacteria. Useful in biochemical ...
-
FcgRllb 131R receptor expressing cell line
<p>CHO cells transfected to express human FcgRllb allotype 131R as a transmembrane ...
Latest news
-
Eight19 begins organic solar trials in Africa
Real-world data will accelerate product development
-
BlueGnome technology shown to increase IVF success rates by 65%
The chromosome screening technology developed by University of Cambridge spin-out BlueGnome has ...
Latest funding events
-
BBSRC Super Follow on Funding
A small number of larger strategic awards are available called Super follow-on ...
-
BBSRC - Follow-on funding
This funding is for ‘proof of concept’ at the very early stage ...
